Industry Research Reports

Home > Reports > Chemical & Material > Global Milbemycin Oxime API Market Research Report 2023

Global Milbemycin Oxime API Market Research Report 2023

Industry: Chemical & Material

Published: 2023-07-31

Pages: 66 Pages

Report ld: 1616596

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Milbemycin is a new type of semi-synthetic macrolide anthelmintic. It is an oxime derivative of Milbemycin A3 and A4. The molecular weight of A3 oxime is 541.7, and the molecular weight of A4 oxime is 555.7. In terms of application, milbexime can be used alone or in combination with nitenpyram, lufenuron, spinosad, praziquantel, etc. to form a compound preparation, which can effectively prevent and control heartworms, hookworms, roundworms, whipworms, roundworms and other internal parasites, as well as hair follicles, scabies, lice, fleas and other external parasites. Milbexime acts as an agonist of the GABA (gamma-aminobutyric acid) neurotransmitter in nerve cells and also binds to glutamate-gated Cl– channels in invertebrate nerve and muscle cells. In both cases, it blocks the parasite's nerve signaling, eventually paralyzing the parasite, causing the muscles to lose their ability to contract, stop feeding, and cause the parasite to die.

According to QYResearch’s new survey, global Milbemycin Oxime API market is projected to reach US$ 304 million in 2029, increasing from US$ 183.7 million in 2022, with the CAGR of 6.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Milbemycin Oxime API market research.

Global 3 largest manufacturers of Milbemycin Oxime API are Livzon Pharmaceutical Group Inc, Zhejiang Hisun Pharmaceutical Co., Ltd and Hubei Honch Pharmaceutical Co.,Ltd, which make up over 40%. Among them, Livzon Pharmaceutical Group Inc is the leader with about 22% market share. North America is the largest market, with a share about 48%, followed by Europe and China, with the share about 46% and 2%. In terms of product type, Purity Greater than 98% occupy the largest share of the total market, about 85%. And in terms of product Application, the largest application is Dog, followed by Cat.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Milbemycin Oxime API market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company
    Livzon Pharmaceutical Group Inc
    Zhejiang Hisun Pharmaceutical Co., Ltd
    Hubei Honch Pharmaceutical Co.,Ltd
    JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD

Segment by Type
    98% Purity
    Purity Greater than 98%

Segment by Application
    Dog
    Cat
    Other

Production by Region
    China

Consumption by Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Southeast Asia
    Latin America, Middle East & Africa
        Mexico
        Brazil
        Turkey
        GCC Countries

The Milbemycin Oxime API report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Production Region Distribution and Analysis
Chapter 4: Country Level Sales Analysis
Chapter 5: Product Type Analysis
Chapter 6: Product Application Analysis
Chapter 7: Manufacturers’ Outline
Chapter 8: Industry Chain, Market Channel and Customer Analysis
Chapter 9: Market Opportunities and Challenges
Chapter 10: Market Conclusions
Chapter 11: Research Methodology and Data Source

Table of Contents

 1 Milbemycin Oxime API Market Overview
    1.1 Product Definition
    1.2 Milbemycin Oxime API Segment by Type
        1.2.1 Global Milbemycin Oxime API Market Value Growth Rate Analysis by Type 2022 VS 2029
        1.2.2 98% Purity
        1.2.3 Purity Greater than 98%
    1.3 Milbemycin Oxime API Segment by Application
        1.3.1 Global Milbemycin Oxime API Market Value Growth Rate Analysis by Application: 2022 VS 2029
        1.3.2 Dog
        1.3.3 Cat
        1.3.4 Other
    1.4 Global Market Growth Prospects
        1.4.1 Global Milbemycin Oxime API Production Value Estimates and Forecasts (2018-2029)
        1.4.2 Global Milbemycin Oxime API Production Capacity Estimates and Forecasts (2018-2029)
        1.4.3 Global Milbemycin Oxime API Production Estimates and Forecasts (2018-2029)
        1.4.4 Global Milbemycin Oxime API Market Average Price Estimates and Forecasts (2018-2029)
    1.5 Assumptions and Limitations

 2 Market Competition by Manufacturers
    2.1 Global Milbemycin Oxime API Production Market Share by Manufacturers (2018-2023)
    2.2 Global Milbemycin Oxime API Production Value Market Share by Manufacturers (2018-2023)
    2.3 Global Key Players of Milbemycin Oxime API, Industry Ranking, 2021 VS 2022 VS 2023
    2.4 Global Milbemycin Oxime API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.5 Global Milbemycin Oxime API Average Price by Manufacturers (2018-2023)
    2.6 Global Key Manufacturers of Milbemycin Oxime API, Manufacturing Base Distribution and Headquarters
    2.7 Global Key Manufacturers of Milbemycin Oxime API, Product Offered and Application
    2.8 Global Key Manufacturers of Milbemycin Oxime API, Date of Enter into This Industry
    2.9 Milbemycin Oxime API Market Competitive Situation and Trends
        2.9.1 Milbemycin Oxime API Market Concentration Rate
        2.9.2 Global 5 and 10 Largest Milbemycin Oxime API Players Market Share by Revenue
    2.10 Mergers & Acquisitions, Expansion

 3 Milbemycin Oxime API Production by Region
    3.1 Global Milbemycin Oxime API Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
    3.2 Global Milbemycin Oxime API Production Value by Region (2018-2029)
        3.2.1 Global Milbemycin Oxime API Production Value Market Share by Region (2018-2023)
        3.2.2 Global Forecasted Production Value of Milbemycin Oxime API by Region (2024-2029)
    3.3 Global Milbemycin Oxime API Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
    3.4 Global Milbemycin Oxime API Production by Region (2018-2029)
        3.4.1 Global Milbemycin Oxime API Production Market Share by Region (2018-2023)
        3.4.2 Global Forecasted Production of Milbemycin Oxime API by Region (2024-2029)
    3.5 Global Milbemycin Oxime API Market Price Analysis by Region (2018-2023)
    3.6 Global Milbemycin Oxime API Production and Value, Year-over-Year Growth
        3.6.1 China Milbemycin Oxime API Production Value Estimates and Forecasts (2018-2029)

 4 Milbemycin Oxime API Consumption by Region
    4.1 Global Milbemycin Oxime API Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
    4.2 Global Milbemycin Oxime API Consumption by Region (2018-2029)
        4.2.1 Global Milbemycin Oxime API Consumption by Region (2018-2023)
        4.2.2 Global Milbemycin Oxime API Forecasted Consumption by Region (2024-2029)
    4.3 North America
        4.3.1 North America Milbemycin Oxime API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
        4.3.2 North America Milbemycin Oxime API Consumption by Country (2018-2029)
        4.3.3 United States
        4.3.4 Canada
    4.4 Europe
        4.4.1 Europe Milbemycin Oxime API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
        4.4.2 Europe Milbemycin Oxime API Consumption by Country (2018-2029)
        4.4.3 Germany
        4.4.4 France
        4.4.5 U.K.
        4.4.6 Italy
        4.4.7 Russia
    4.5 Asia Pacific
        4.5.1 Asia Pacific Milbemycin Oxime API Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
        4.5.2 Asia Pacific Milbemycin Oxime API Consumption by Region (2018-2029)
        4.5.3 China
        4.5.4 Japan
        4.5.5 South Korea
        4.5.6 China Taiwan
        4.5.7 Southeast Asia
        4.5.8 India
    4.6 Latin America, Middle East & Africa
        4.6.1 Latin America, Middle East & Africa Milbemycin Oxime API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
        4.6.2 Latin America, Middle East & Africa Milbemycin Oxime API Consumption by Country (2018-2029)
        4.6.3 Mexico
        4.6.4 Brazil
        4.6.5 Turkey

 5 Segment by Type
    5.1 Global Milbemycin Oxime API Production by Type (2018-2029)
        5.1.1 Global Milbemycin Oxime API Production by Type (2018-2023)
        5.1.2 Global Milbemycin Oxime API Production by Type (2024-2029)
        5.1.3 Global Milbemycin Oxime API Production Market Share by Type (2018-2029)
    5.2 Global Milbemycin Oxime API Production Value by Type (2018-2029)
        5.2.1 Global Milbemycin Oxime API Production Value by Type (2018-2023)
        5.2.2 Global Milbemycin Oxime API Production Value by Type (2024-2029)
        5.2.3 Global Milbemycin Oxime API Production Value Market Share by Type (2018-2029)
    5.3 Global Milbemycin Oxime API Price by Type (2018-2029)

 6 Segment by Application
    6.1 Global Milbemycin Oxime API Production by Application (2018-2029)
        6.1.1 Global Milbemycin Oxime API Production by Application (2018-2023)
        6.1.2 Global Milbemycin Oxime API Production by Application (2024-2029)
        6.1.3 Global Milbemycin Oxime API Production Market Share by Application (2018-2029)
    6.2 Global Milbemycin Oxime API Production Value by Application (2018-2029)
        6.2.1 Global Milbemycin Oxime API Production Value by Application (2018-2023)
        6.2.2 Global Milbemycin Oxime API Production Value by Application (2024-2029)
        6.2.3 Global Milbemycin Oxime API Production Value Market Share by Application (2018-2029)
    6.3 Global Milbemycin Oxime API Price by Application (2018-2029)

 7 Key Companies Profiled
    7.1 Livzon Pharmaceutical Group Inc
        7.1.1 Livzon Pharmaceutical Group Inc Milbemycin Oxime API Corporation Information
        7.1.2 Livzon Pharmaceutical Group Inc Milbemycin Oxime API Product Portfolio
        7.1.3 Livzon Pharmaceutical Group Inc Milbemycin Oxime API Production, Value, Price and Gross Margin (2018-2023)
        7.1.4 Livzon Pharmaceutical Group Inc Main Business and Markets Served
        7.1.5 Livzon Pharmaceutical Group Inc Recent Developments/Updates
    7.2 Zhejiang Hisun Pharmaceutical Co., Ltd
        7.2.1 Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Corporation Information
        7.2.2 Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Product Portfolio
        7.2.3 Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Production, Value, Price and Gross Margin (2018-2023)
        7.2.4 Zhejiang Hisun Pharmaceutical Co., Ltd Main Business and Markets Served
        7.2.5 Zhejiang Hisun Pharmaceutical Co., Ltd Recent Developments/Updates
    7.3 Hubei Honch Pharmaceutical Co.,Ltd
        7.3.1 Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Corporation Information
        7.3.2 Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Product Portfolio
        7.3.3 Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Production, Value, Price and Gross Margin (2018-2023)
        7.3.4 Hubei Honch Pharmaceutical Co.,Ltd Main Business and Markets Served
        7.3.5 Hubei Honch Pharmaceutical Co.,Ltd Recent Developments/Updates
    7.4 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD
        7.4.1 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Corporation Information
        7.4.2 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Product Portfolio
        7.4.3 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Production, Value, Price and Gross Margin (2018-2023)
        7.4.4 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Main Business and Markets Served
        7.4.5 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Recent Developments/Updates

 8 Industry Chain and Sales Channels Analysis
    8.1 Milbemycin Oxime API Industry Chain Analysis
    8.2 Milbemycin Oxime API Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
    8.3 Milbemycin Oxime API Production Mode & Process
    8.4 Milbemycin Oxime API Sales and Marketing
        8.4.1 Milbemycin Oxime API Sales Channels
        8.4.2 Milbemycin Oxime API Distributors
    8.5 Milbemycin Oxime API Customers

 9 Milbemycin Oxime API Market Dynamics
    9.1 Milbemycin Oxime API Industry Trends
    9.2 Milbemycin Oxime API Market Drivers
    9.3 Milbemycin Oxime API Market Challenges
    9.4 Milbemycin Oxime API Market Restraints

 10 Research Finding and Conclusion

 11 Methodology and Data Source
    11.1 Methodology/Research Approach
        11.1.1 Research Programs/Design
        11.1.2 Market Size Estimation
        11.1.3 Market Breakdown and Data Triangulation
    11.2 Data Source
        11.2.1 Secondary Sources
        11.2.2 Primary Sources
    11.3 Author List
    11.4 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Milbemycin Oxime API Market Value by Type, (US$ Million) & (2022 VS 2029)
    Table 2. Global Milbemycin Oxime API Market Value by Application, (US$ Million) & (2022 VS 2029)
    Table 3. Global Milbemycin Oxime API Production Capacity (KG) by Manufacturers in 2022
    Table 4. Global Milbemycin Oxime API Production by Manufacturers (2018-2023) & (KG)
    Table 5. Global Milbemycin Oxime API Production Market Share by Manufacturers (2018-2023)
    Table 6. Global Milbemycin Oxime API Production Value by Manufacturers (2018-2023) & (US$ Million)
    Table 7. Global Milbemycin Oxime API Production Value Share by Manufacturers (2018-2023)
    Table 8. Global Milbemycin Oxime API Industry Ranking 2021 VS 2022 VS 2023
    Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Milbemycin Oxime API as of 2022)
    Table 10. Global Market Milbemycin Oxime API Average Price by Manufacturers (US$/KG) & (2018-2023)
    Table 11. Manufacturers Milbemycin Oxime API Production Sites and Area Served
    Table 12. Manufacturers Milbemycin Oxime API Product Types
    Table 13. Global Milbemycin Oxime API Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Mergers & Acquisitions, Expansion
    Table 15. Global Milbemycin Oxime API Production Value by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 16. Global Milbemycin Oxime API Production Value (US$ Million) by Region (2018-2023)
    Table 17. Global Milbemycin Oxime API Production Value Market Share by Region (2018-2023)
    Table 18. Global Milbemycin Oxime API Production Value (US$ Million) Forecast by Region (2024-2029)
    Table 19. Global Milbemycin Oxime API Production Value Market Share Forecast by Region (2024-2029)
    Table 20. Global Milbemycin Oxime API Production Comparison by Region: 2018 VS 2022 VS 2029 (KG)
    Table 21. Global Milbemycin Oxime API Production (KG) by Region (2018-2023)
    Table 22. Global Milbemycin Oxime API Production Market Share by Region (2018-2023)
    Table 23. Global Milbemycin Oxime API Production (KG) Forecast by Region (2024-2029)
    Table 24. Global Milbemycin Oxime API Production Market Share Forecast by Region (2024-2029)
    Table 25. Global Milbemycin Oxime API Market Average Price (US$/KG) by Region (2018-2023)
    Table 26. Global Milbemycin Oxime API Market Average Price (US$/KG) by Region (2024-2029)
    Table 27. Global Milbemycin Oxime API Consumption Growth Rate by Region: 2018 VS 2022 VS 2029 (KG)
    Table 28. Global Milbemycin Oxime API Consumption by Region (2018-2023) & (KG)
    Table 29. Global Milbemycin Oxime API Consumption Market Share by Region (2018-2023)
    Table 30. Global Milbemycin Oxime API Forecasted Consumption by Region (2024-2029) & (KG)
    Table 31. Global Milbemycin Oxime API Forecasted Consumption Market Share by Region (2018-2023)
    Table 32. North America Milbemycin Oxime API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (KG)
    Table 33. North America Milbemycin Oxime API Consumption by Country (2018-2023) & (KG)
    Table 34. North America Milbemycin Oxime API Consumption by Country (2024-2029) & (KG)
    Table 35. Europe Milbemycin Oxime API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (KG)
    Table 36. Europe Milbemycin Oxime API Consumption by Country (2018-2023) & (KG)
    Table 37. Europe Milbemycin Oxime API Consumption by Country (2024-2029) & (KG)
    Table 38. Asia Pacific Milbemycin Oxime API Consumption Growth Rate by Region: 2018 VS 2022 VS 2029 (KG)
    Table 39. Asia Pacific Milbemycin Oxime API Consumption by Region (2018-2023) & (KG)
    Table 40. Asia Pacific Milbemycin Oxime API Consumption by Region (2024-2029) & (KG)
    Table 41. Latin America, Middle East & Africa Milbemycin Oxime API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (KG)
    Table 42. Latin America, Middle East & Africa Milbemycin Oxime API Consumption by Country (2018-2023) & (KG)
    Table 43. Latin America, Middle East & Africa Milbemycin Oxime API Consumption by Country (2024-2029) & (KG)
    Table 44. Global Milbemycin Oxime API Production (KG) by Type (2018-2023)
    Table 45. Global Milbemycin Oxime API Production (KG) by Type (2024-2029)
    Table 46. Global Milbemycin Oxime API Production Market Share by Type (2018-2023)
    Table 47. Global Milbemycin Oxime API Production Market Share by Type (2024-2029)
    Table 48. Global Milbemycin Oxime API Production Value (US$ Million) by Type (2018-2023)
    Table 49. Global Milbemycin Oxime API Production Value (US$ Million) by Type (2024-2029)
    Table 50. Global Milbemycin Oxime API Production Value Share by Type (2018-2023)
    Table 51. Global Milbemycin Oxime API Production Value Share by Type (2024-2029)
    Table 52. Global Milbemycin Oxime API Price (US$/KG) by Type (2018-2023)
    Table 53. Global Milbemycin Oxime API Price (US$/KG) by Type (2024-2029)
    Table 54. Global Milbemycin Oxime API Production (KG) by Application (2018-2023)
    Table 55. Global Milbemycin Oxime API Production (KG) by Application (2024-2029)
    Table 56. Global Milbemycin Oxime API Production Market Share by Application (2018-2023)
    Table 57. Global Milbemycin Oxime API Production Market Share by Application (2024-2029)
    Table 58. Global Milbemycin Oxime API Production Value (US$ Million) by Application (2018-2023)
    Table 59. Global Milbemycin Oxime API Production Value (US$ Million) by Application (2024-2029)
    Table 60. Global Milbemycin Oxime API Production Value Share by Application (2018-2023)
    Table 61. Global Milbemycin Oxime API Production Value Share by Application (2024-2029)
    Table 62. Global Milbemycin Oxime API Price (US$/KG) by Application (2018-2023)
    Table 63. Global Milbemycin Oxime API Price (US$/KG) by Application (2024-2029)
    Table 64. Livzon Pharmaceutical Group Inc Milbemycin Oxime API Corporation Information
    Table 65. Livzon Pharmaceutical Group Inc Specification and Application
    Table 66. Livzon Pharmaceutical Group Inc Milbemycin Oxime API Production (KG), Value (US$ Million), Price (US$/KG) and Gross Margin (2018-2023)
    Table 67. Livzon Pharmaceutical Group Inc Main Business and Markets Served
    Table 68. Livzon Pharmaceutical Group Inc Recent Developments/Updates
    Table 69. Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Corporation Information
    Table 70. Zhejiang Hisun Pharmaceutical Co., Ltd Specification and Application
    Table 71. Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Production (KG), Value (US$ Million), Price (US$/KG) and Gross Margin (2018-2023)
    Table 72. Zhejiang Hisun Pharmaceutical Co., Ltd Main Business and Markets Served
    Table 73. Zhejiang Hisun Pharmaceutical Co., Ltd Recent Developments/Updates
    Table 74. Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Corporation Information
    Table 75. Hubei Honch Pharmaceutical Co.,Ltd Specification and Application
    Table 76. Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Production (KG), Value (US$ Million), Price (US$/KG) and Gross Margin (2018-2023)
    Table 77. Hubei Honch Pharmaceutical Co.,Ltd Main Business and Markets Served
    Table 78. Hubei Honch Pharmaceutical Co.,Ltd Recent Developments/Updates
    Table 79. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Corporation Information
    Table 80. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Specification and Application
    Table 81. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Production (KG), Value (US$ Million), Price (US$/KG) and Gross Margin (2018-2023)
    Table 82. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Main Business and Markets Served
    Table 83. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Recent Developments/Updates
    Table 84. Key Raw Materials Lists
    Table 85. Raw Materials Key Suppliers Lists
    Table 86. Milbemycin Oxime API Distributors List
    Table 87. Milbemycin Oxime API Customers List
    Table 88. Milbemycin Oxime API Market Trends
    Table 89. Milbemycin Oxime API Market Drivers
    Table 90. Milbemycin Oxime API Market Challenges
    Table 91. Milbemycin Oxime API Market Restraints
    Table 92. Research Programs/Design for This Report
    Table 93. Key Data Information from Secondary Sources
    Table 94. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Milbemycin Oxime API
    Figure 2. Global Milbemycin Oxime API Market Value by Type, (US$ Million) & (2022 VS 2029)
    Figure 3. Global Milbemycin Oxime API Market Share by Type: 2022 VS 2029
    Figure 4. 98% Purity Product Picture
    Figure 5. Purity Greater than 98% Product Picture
    Figure 6. Global Milbemycin Oxime API Market Value by Application, (US$ Million) & (2022 VS 2029)
    Figure 7. Global Milbemycin Oxime API Market Share by Application: 2022 VS 2029
    Figure 8. Dog
    Figure 9. Cat
    Figure 10. Other
    Figure 11. Global Milbemycin Oxime API Production Value (US$ Million), 2018 VS 2022 VS 2029
    Figure 12. Global Milbemycin Oxime API Production Value (US$ Million) & (2018-2029)
    Figure 13. Global Milbemycin Oxime API Production Capacity (KG) & (2018-2029)
    Figure 14. Global Milbemycin Oxime API Production (KG) & (2018-2029)
    Figure 15. Global Milbemycin Oxime API Average Price (US$/KG) & (2018-2029)
    Figure 16. Milbemycin Oxime API Report Years Considered
    Figure 17. Milbemycin Oxime API Production Share by Manufacturers in 2022
    Figure 18. Milbemycin Oxime API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 19. The Global 5 and 10 Largest Players: Market Share by Milbemycin Oxime API Revenue in 2022
    Figure 20. Global Milbemycin Oxime API Production Value by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Figure 21. Global Milbemycin Oxime API Production Value Market Share by Region: 2018 VS 2022 VS 2029
    Figure 22. Global Milbemycin Oxime API Production Comparison by Region: 2018 VS 2022 VS 2029 (KG)
    Figure 23. Global Milbemycin Oxime API Production Market Share by Region: 2018 VS 2022 VS 2029
    Figure 24. China Milbemycin Oxime API Production Value (US$ Million) Growth Rate (2018-2029)
    Figure 25. Global Milbemycin Oxime API Consumption by Region: 2018 VS 2022 VS 2029 (KG)
    Figure 26. Global Milbemycin Oxime API Consumption Market Share by Region: 2018 VS 2022 VS 2029
    Figure 27. North America Milbemycin Oxime API Consumption and Growth Rate (2018-2023) & (KG)
    Figure 28. North America Milbemycin Oxime API Consumption Market Share by Country (2018-2029)
    Figure 29. Canada Milbemycin Oxime API Consumption and Growth Rate (2018-2023) & (KG)
    Figure 30. U.S. Milbemycin Oxime API Consumption and Growth Rate (2018-2023) & (KG)
    Figure 31. Europe Milbemycin Oxime API Consumption and Growth Rate (2018-2023) & (KG)
    Figure 32. Europe Milbemycin Oxime API Consumption Market Share by Country (2018-2029)
    Figure 33. Germany Milbemycin Oxime API Consumption and Growth Rate (2018-2023) & (KG)
    Figure 34. France Milbemycin Oxime API Consumption and Growth Rate (2018-2023) & (KG)
    Figure 35. U.K. Milbemycin Oxime API Consumption and Growth Rate (2018-2023) & (KG)
    Figure 36. Italy Milbemycin Oxime API Consumption and Growth Rate (2018-2023) & (KG)
    Figure 37. Russia Milbemycin Oxime API Consumption and Growth Rate (2018-2023) & (KG)
    Figure 38. Asia Pacific Milbemycin Oxime API Consumption and Growth Rate (2018-2023) & (KG)
    Figure 39. Asia Pacific Milbemycin Oxime API Consumption Market Share by Regions (2018-2029)
    Figure 40. China Milbemycin Oxime API Consumption and Growth Rate (2018-2023) & (KG)
    Figure 41. Japan Milbemycin Oxime API Consumption and Growth Rate (2018-2023) & (KG)
    Figure 42. South Korea Milbemycin Oxime API Consumption and Growth Rate (2018-2023) & (KG)
    Figure 43. China Taiwan Milbemycin Oxime API Consumption and Growth Rate (2018-2023) & (KG)
    Figure 44. Southeast Asia Milbemycin Oxime API Consumption and Growth Rate (2018-2023) & (KG)
    Figure 45. India Milbemycin Oxime API Consumption and Growth Rate (2018-2023) & (KG)
    Figure 46. Latin America, Middle East & Africa Milbemycin Oxime API Consumption and Growth Rate (2018-2023) & (KG)
    Figure 47. Latin America, Middle East & Africa Milbemycin Oxime API Consumption Market Share by Country (2018-2029)
    Figure 48. Mexico Milbemycin Oxime API Consumption and Growth Rate (2018-2023) & (KG)
    Figure 49. Brazil Milbemycin Oxime API Consumption and Growth Rate (2018-2023) & (KG)
    Figure 50. Turkey Milbemycin Oxime API Consumption and Growth Rate (2018-2023) & (KG)
    Figure 51. GCC Countries Milbemycin Oxime API Consumption and Growth Rate (2018-2023) & (KG)
    Figure 52. Global Production Market Share of Milbemycin Oxime API by Type (2018-2029)
    Figure 53. Global Production Value Market Share of Milbemycin Oxime API by Type (2018-2029)
    Figure 54. Global Milbemycin Oxime API Price (US$/KG) by Type (2018-2029)
    Figure 55. Global Production Market Share of Milbemycin Oxime API by Application (2018-2029)
    Figure 56. Global Production Value Market Share of Milbemycin Oxime API by Application (2018-2029)
    Figure 57. Global Milbemycin Oxime API Price (US$/KG) by Application (2018-2029)
    Figure 58. Milbemycin Oxime API Value Chain
    Figure 59. Milbemycin Oxime API Production Process
    Figure 60. Channels of Distribution (Direct Vs Distribution)
    Figure 61. Distributors Profiles
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation

Description

Milbemycin is a new type of semi-synthetic macrolide anthelmintic. It is an oxime derivative of Milbemycin A3 and A4. The molecular weight of A3 oxime is 541.7, and the molecular weight of A4 oxime is 555.7. In terms of application, milbexime can be used alone or in combination with nitenpyram, lufenuron, spinosad, praziquantel, etc. to form a compound preparation, which can effectively prevent and control heartworms, hookworms, roundworms, whipworms, roundworms and other internal parasites, as well as hair follicles, scabies, lice, fleas and other external parasites. Milbexime acts as an agonist of the GABA (gamma-aminobutyric acid) neurotransmitter in nerve cells and also binds to glutamate-gated Cl– channels in invertebrate nerve and muscle cells. In both cases, it blocks the parasite's nerve signaling, eventually paralyzing the parasite, causing the muscles to lose their ability to contract, stop feeding, and cause the parasite to die.

According to QYResearch’s new survey, global Milbemycin Oxime API market is projected to reach US$ 304 million in 2029, increasing from US$ 183.7 million in 2022, with the CAGR of 6.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Milbemycin Oxime API market research.

Global 3 largest manufacturers of Milbemycin Oxime API are Livzon Pharmaceutical Group Inc, Zhejiang Hisun Pharmaceutical Co., Ltd and Hubei Honch Pharmaceutical Co.,Ltd, which make up over 40%. Among them, Livzon Pharmaceutical Group Inc is the leader with about 22% market share. North America is the largest market, with a share about 48%, followed by Europe and China, with the share about 46% and 2%. In terms of product type, Purity Greater than 98% occupy the largest share of the total market, about 85%. And in terms of product Application, the largest application is Dog, followed by Cat.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Milbemycin Oxime API market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company
    Livzon Pharmaceutical Group Inc
    Zhejiang Hisun Pharmaceutical Co., Ltd
    Hubei Honch Pharmaceutical Co.,Ltd
    JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD

Segment by Type
    98% Purity
    Purity Greater than 98%

Segment by Application
    Dog
    Cat
    Other

Production by Region
    China

Consumption by Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Southeast Asia
    Latin America, Middle East & Africa
        Mexico
        Brazil
        Turkey
        GCC Countries

The Milbemycin Oxime API report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Production Region Distribution and Analysis
Chapter 4: Country Level Sales Analysis
Chapter 5: Product Type Analysis
Chapter 6: Product Application Analysis
Chapter 7: Manufacturers’ Outline
Chapter 8: Industry Chain, Market Channel and Customer Analysis
Chapter 9: Market Opportunities and Challenges
Chapter 10: Market Conclusions
Chapter 11: Research Methodology and Data Source

Industry: Chemical & Material

Published: 2023-07-31

Pages: 66 Pages

Report ld: 1616596

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 2900.00

Multi Users License

USD 4350.00

Corporate Users License